Talicia is also approved and launched in the UAE and additional countries may accept UK MHRA approvals as a reference for their own marketing approval processes
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Alkem Medtech to acquire 100% stake of Bombay Ortho
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Empamore is poised to make a significant impact by offering high-quality treatment at an affordable price point, empowering millions of Indians to take control of their health
Experts urge early detection & better access to care
Amexel aims to generate revenue through facilitation services and a profit-sharing model linked to the commercialization of products
The programme will take place on the 2nd Sunday of every month
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
Subscribe To Our Newsletter & Stay Updated
